Hologic and Ostex in strategic alliance:
This article was originally published in Clinica
Executive Summary
US companies Hologic and Ostex International have announced a strategic alliance under which they will co-market their respective bone assessment products. They will also develop a low-cost point-of-care NTx test for bone resorption, based on Ostex' Osteomark assay and utilising strip-test technology developed by a third company, Serex.